MicroRNA-544 attenuates diabetic renal injury via suppressing glomerulosclerosis and inflammation by targeting FASN.

In conclusion, our finding demonstrated that miR-544 attenuates diabetic renal injury via suppressing glomerulosclerosis and inflammation by targeting FASN, suggesting that miR-544 might have therapeutic potential for the treatment of DN.
PMID: 31323309 [PubMed - as supplied by publisher]

Source: Gene - July 15, 2019 Category: Genetics & Stem Cells Authors: Sun T, Liu Y, Liu L, Ma F Tags: Gene Source Type: research